A commonly-used HIV drug has been shown to kill-off the human papilloma virus (HPV) that leads to cervical cancer in a world-first clinical trial led by The University of Manchester with Kenyatta National Hospital (KNH) in Nairobi.
Drs Ian and Lynne Hampson, from the University’s Institute of Cancer Sciences and Dr Innocent Orora Maranga, Consultant in Obstetrics and Gynaecology at KNH in Nairobi examined Kenyan women diagnosed with HPV positive early stage cervical cancer who were treated with the antiviral HIV drug lopinavir in Kenya.
Continue reading HIV drug used to reverse effects of virus that causes cervical cancer
More than 100 Walgreens Pharmacies Designated Hepatitis C-Specialized to Meet Projected Patient Care Management Needs and Improve Medication Adherence.
With new advances in treatment therapy now available for hepatitis C patients, Walgreens (NYSE:WAG) (Nasdaq:WAG) today announced it is expanding access to Walgreens Connected Caresm hepatitis C program through its more than 100 hepatitis C-specialized pharmacies. Walgreens Connected Care is an education and support plan designed to help patients achieve a sustained virologic response (SVR) and improved quality of life through medication adherence.
Continue reading Walgreens Expands Access to Pharmacist-Led Hepatitis C Care as Treatments Advance
The UNAIDS and Lancet Commission: Defeating AIDS – Advancing global health, reconvenes in London for final meeting on the future of HIV and global health.
LONDON/GENEVA, 13 February 2014—The UNAIDS and Lancet Commission: Defeating AIDS – Advancing global health is meeting in London on the future of AIDS and global health in the post-2015 era—the recommendations will be published in The Lancet later this year.
Continue reading UNAIDS and Lancet Commission to put forward recommendations on AIDS and global health for the post-2015 debate
AS INVESTORS and executives crammed into a New York ballroom for a conference held this week by the Biotechnology Industry Organisation, the mood was jittery.
The previous week eight biotech firms had launched initial public offerings in America, together raising more than $500m. In a discussion panel on whether the industry’s latest boom will last, a prominent investor, Oleg Nodelman, joked that he still had suitcases of cash for any firm that wanted it.
Continue reading Why The Latest Biotech Boom May Not Be Followed By Another Bust
Marijuana or “weed” is now among the several ingredients that researchers are looking into to helping stop further spread of HIV infection.
According to hundreds of marijuana researchers, an active ingredient on “weeds” known as THC pierced HIV-like virus in monkeys called RIV.
Continue reading HIV Cure: Medical Cannabis Or ‘Weed’ Explored To Help Stop HIV Infection Using THC Component; Laws Prevent Clinical Trials On Humans